
Sharon M. Papciak
Examiner (ID: 15460)
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1657 |
| Total Applications | 611 |
| Issued Applications | 263 |
| Pending Applications | 90 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19684324
[patent_doc_number] => 20250002869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => Burkholderia pseudomallei (Bp) phage vB BpP HN01 and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/345524
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345524
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345524 | Burkholderia pseudomallei (Bp) phage vB BpP HN01 and use thereof | Jun 29, 2023 | Pending |
Array
(
[id] => 18752304
[patent_doc_number] => 20230355525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/214335
[patent_app_country] => US
[patent_app_date] => 2023-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18214335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/214335 | Exosomal compositions and methods for the treatment of disease | Jun 25, 2023 | Issued |
Array
(
[id] => 18829670
[patent_doc_number] => 20230398194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE
[patent_app_type] => utility
[patent_app_number] => 18/323578
[patent_app_country] => US
[patent_app_date] => 2023-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323578
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/323578 | METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE | May 24, 2023 | Pending |
Array
(
[id] => 18877587
[patent_doc_number] => 20240000956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => PAN DOMAIN ACTIVATES UBIQUITINATION
[patent_app_type] => utility
[patent_app_number] => 18/323672
[patent_app_country] => US
[patent_app_date] => 2023-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18323672
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/323672 | PAN DOMAIN ACTIVATES UBIQUITINATION | May 24, 2023 | Pending |
Array
(
[id] => 18675561
[patent_doc_number] => 20230313170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHOD FOR PRODUCING THERAPEUTIC EXOSOMES FROM NANOELECTROPORATION AND OTHER NON-ENDOCYTIC CELL TRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 18/199442
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199442
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199442 | Method for producing therapeutic exosomes from nanoelectroporation and other non-endocytic cell transfection | May 18, 2023 | Issued |
Array
(
[id] => 18769388
[patent_doc_number] => 20230364149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHOD FOR TREATING HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 18/318877
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318877 | Method for treating heart failure | May 16, 2023 | Issued |
Array
(
[id] => 19584983
[patent_doc_number] => 20240382540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 18/317422
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/317422 | MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE | May 14, 2023 | Pending |
Array
(
[id] => 18923327
[patent_doc_number] => 20240026331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => RECOMBINANT NEPROSIN POLYPEPTIDES AND METHODS OF EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/315466
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18315466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/315466 | RECOMBINANT NEPROSIN POLYPEPTIDES AND METHODS OF EXPRESSION | May 9, 2023 | Pending |
Array
(
[id] => 18772057
[patent_doc_number] => 20230366879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => CAPTURE, PURIFICATION, AND RELEASE OF BIOLOGICAL SUBSTANCES USING A SURFACE COATING
[patent_app_type] => utility
[patent_app_number] => 18/308531
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308531
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308531 | CAPTURE, PURIFICATION, AND RELEASE OF BIOLOGICAL SUBSTANCES USING A SURFACE COATING | Apr 26, 2023 | Abandoned |
Array
(
[id] => 18550649
[patent_doc_number] => 20230248649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/129593
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18129593
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/129593 | EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE | Mar 30, 2023 | Abandoned |
Array
(
[id] => 18953617
[patent_doc_number] => 20240041944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => OPTIMIZED INDIVIDUALIZED PREBIOTIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/181504
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181504
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181504 | OPTIMIZED INDIVIDUALIZED PREBIOTIC COMPOSITIONS | Mar 8, 2023 | Abandoned |
Array
(
[id] => 18510031
[patent_doc_number] => 20230226128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => COMPOSITION OF LACTIC BACTERIA FOR USE IN THE TREATMENT OF INFECTIONS DUE TO PROPIONIBACTERIUM ACNES AND IN PARTICULAR FOR ACNE
[patent_app_type] => utility
[patent_app_number] => 18/115752
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/115752 | COMPOSITION OF LACTIC BACTERIA FOR USE IN THE TREATMENT OF INFECTIONS DUE TO PROPIONIBACTERIUM ACNES AND IN PARTICULAR FOR ACNE | Feb 27, 2023 | Pending |
Array
(
[id] => 19096398
[patent_doc_number] => 20240115625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => ROSEBURIA HOMINIS, EUBACTERIUM ELIGENS, AND COMBINATIONS THEREOF AS BIOTHERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 18/112242
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112242
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112242 | ROSEBURIA HOMINIS, EUBACTERIUM ELIGENS, AND COMBINATIONS THEREOF AS BIOTHERAPEUTICS | Feb 20, 2023 | Abandoned |
Array
(
[id] => 18626680
[patent_doc_number] => 20230285480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/097096
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18097096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/097096 | VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE | Jan 12, 2023 | Pending |
Array
(
[id] => 18483620
[patent_doc_number] => 20230210921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/062221
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062221 | BIFIDOBACTERIUM LONGUM ABLE TO BENEFICIALLY MODULATE IMMUNE RESPONSE TO RESPIRATORY VIRUS INFECTION | Dec 5, 2022 | Abandoned |
Array
(
[id] => 18335018
[patent_doc_number] => 20230126966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => SYNTHETIC QUORUM-REGULATED LYSIS
[patent_app_type] => utility
[patent_app_number] => 18/072256
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18072256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/072256 | SYNTHETIC QUORUM-REGULATED LYSIS | Nov 29, 2022 | Abandoned |
Array
(
[id] => 18467038
[patent_doc_number] => 20230201318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS
[patent_app_type] => utility
[patent_app_number] => 18/057483
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057483
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057483 | METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS | Nov 20, 2022 | Abandoned |
Array
(
[id] => 18244980
[patent_doc_number] => 20230077291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => BACILLUS AMYLOLIQUEFACIENS FCC1256 COMPOSITIONS AND METHODS OF CONTROLLING PLANT PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/988448
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988448 | None | Nov 15, 2022 | Issued |
Array
(
[id] => 18656216
[patent_doc_number] => 20230302100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => CYSTEINE PROTEASE
[patent_app_type] => utility
[patent_app_number] => 18/053676
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053676
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053676 | CYSTEINE PROTEASE | Nov 7, 2022 | Pending |
Array
(
[id] => 18831943
[patent_doc_number] => 20230400470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => DETECTION OF COMPLEMENT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/052795
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052795 | DETECTION OF COMPLEMENT PROTEINS | Nov 3, 2022 | Pending |